Home › Leukemia › Minnesota › Rochester
Leukemia clinical trials in Rochester, MN
5 studies for Leukemia are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
RecruitingPhase 3
- Research Site, Rochester
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecruitingPhase 1/2
- Mayo Clinic, Clinical Trials Referral Office, Rochester
Hairy Cell Leukemia Patient Data Registry
RecruitingObservational study
- Mayo Clinic, Rochester
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- Mayo Clinic - Rochester, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
- Mayo Clinic, Rochester
About Leukemia
Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.
More about Leukemia on MedlinePlus
Leukemia trials in other cities
- Houston, TX28 studies
- Boston, MA25 studies
- New York City, NY19 studies
- Chicago, IL16 studies
- Los Angeles, CA16 studies
- Durham, NC13 studies
- Philadelphia, PA12 studies
- Columbus, OH12 studies
- Nashville, TN12 studies
- Baldwin Park, CA12 studies
- Milwaukee, WI11 studies
- Seattle, WA11 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer38 studies
- Cancer (all types)31 studies
- Metastatic Cancer30 studies
- Colorectal Cancer29 studies
- Ovarian Cancer29 studies
- Pancreatic Cancer23 studies
- Multiple Myeloma23 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Lung Cancer20 studies
- Chronic Lymphocytic Leukemia19 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.